• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖与老年植入式心脏复律除颤器患者的死亡率降低有关。

Presence of obesity is associated with lower mortality in elderly patients with implantable cardioverter defibrillator.

机构信息

Center for Integrative Research on Cardiovascular Aging (CIRCA), Aurora Research Institute, Aurora Health Care, Aurora University of Wisconsin Medical Group, Milwaukee, WI, USA.

Aurora Cardiovascular Services, Aurora Sinai/ Aurora St Luke's Medical Centers, Milwaukee, WI, USA.

出版信息

Int J Obes (Lond). 2018 Feb;42(2):169-174. doi: 10.1038/ijo.2017.211. Epub 2017 Aug 30.

DOI:10.1038/ijo.2017.211
PMID:28852203
Abstract

BACKGROUND

Higher body mass index (BMI) is associated with greater prevalence of cardiovascular risk factors, yet an inverse relationship between obesity and survival after cardiovascular events has been described. It is unclear whether a similar relationship exists for patients with implantable cardioverter defibrillators (ICDs) at high risk for mortality. We aimed to assess the impact of BMI on mortality and cardiovascular hospitalization in patients with ICD.

METHODS

Patients who underwent ICD implantation in 2010-2011 were divided into normal (<25 kg m), overweight (25-29.9 kg m) and obese (⩾30 kg m) groups based on BMI. Clinical parameters were compared and long-term outcomes were determined using χ test, Wilcoxon's rank-sum test, logistic regression models and Kaplan-Meier curves.

RESULTS

Of 904 patients (mean age 67±13 years), 26% had normal BMI, 32% were overweight and 42% were obese. No significant baseline differences in ventricular ejection fraction, ICD for primary or secondary prevention, history of heart failure, syncope or cardiac arrest existed. Despite a greater prevalence of diabetes, hypertension and prior myocardial infarction, the obese and overweight groups had lower mortality (10.1% and 7.9%, respectively) than the normal group (22.9%, P<0.001). On multivariate logistic regression, BMI in the obese and overweight range (odds ratio (OR): 0.35; 95% confidence interval (CI): 0.21-0.58 and OR: 0.25; 95% CI: 0.13-0.40, respectively) was protective against mortality, whereas history of diabetes (OR: 2.01; 95% CI: 1.30-3.09), myocardial infarction (OR: 1.76; 95% CI: 1.11-2.80), heart failure (OR: 3.88; 95% CI: 1.56-9.66), stroke (OR: 3.19; 95% CI: 1.63-6.23) and history of cardiac arrest (OR: 2.65; 95% CI: 1.37-5.15) were independent risk factors for higher mortality.

CONCLUSIONS

A paradoxical relationship between BMI and mortality risk is present in elderly patients with ICD at high risk of sudden death with a lower mortality in obese or overweight patients than in those with normal BMI.

摘要

背景

较高的体重指数(BMI)与心血管危险因素的患病率较高相关,但已描述肥胖与心血管事件后生存之间呈反比关系。对于植入式心脏复律除颤器(ICD)的高死亡率患者,是否存在类似的关系尚不清楚。我们旨在评估 BMI 对 ICD 患者死亡率和心血管住院的影响。

方法

根据 BMI 将 2010-2011 年接受 ICD 植入的患者分为正常(<25kg/m)、超重(25-29.9kg/m)和肥胖(⩾30kg/m)组。比较临床参数,并使用卡方检验、Wilcoxon 秩和检验、逻辑回归模型和 Kaplan-Meier 曲线确定长期结局。

结果

在 904 例患者(平均年龄 67±13 岁)中,26%的患者 BMI 正常,32%的患者超重,42%的患者肥胖。心室射血分数、ICD 用于一级或二级预防、心力衰竭史、晕厥或心搏骤停等基线差异无统计学意义。尽管糖尿病、高血压和既往心肌梗死的患病率较高,但肥胖组和超重组的死亡率(分别为 10.1%和 7.9%)低于正常组(22.9%,P<0.001)。多变量逻辑回归显示,肥胖和超重范围的 BMI(比值比(OR):0.35;95%置信区间(CI):0.21-0.58 和 OR:0.25;95%CI:0.13-0.40)是死亡率的保护因素,而糖尿病史(OR:2.01;95%CI:1.30-3.09)、心肌梗死(OR:1.76;95%CI:1.11-2.80)、心力衰竭(OR:3.88;95%CI:1.56-9.66)、中风(OR:3.19;95%CI:1.63-6.23)和心搏骤停史(OR:2.65;95%CI:1.37-5.15)是更高死亡率的独立危险因素。

结论

在植入 ICD 的高危猝死老年患者中,BMI 与死亡率风险之间存在矛盾关系,肥胖或超重患者的死亡率低于 BMI 正常患者。

相似文献

1
Presence of obesity is associated with lower mortality in elderly patients with implantable cardioverter defibrillator.肥胖与老年植入式心脏复律除颤器患者的死亡率降低有关。
Int J Obes (Lond). 2018 Feb;42(2):169-174. doi: 10.1038/ijo.2017.211. Epub 2017 Aug 30.
2
Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator.超重和肥胖是植入式心脏复律除颤器治疗非缺血性心肌病患者死亡率的保护因素。
Clin Cardiol. 2020 Dec;43(12):1435-1442. doi: 10.1002/clc.23458. Epub 2020 Sep 16.
3
Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data Registry.低体重指数而非肥胖与植入式心脏复律除颤器受者的院内不良事件和死亡率相关:来自全国心血管数据注册中心的见解。
J Am Heart Assoc. 2012 Dec;1(6):e003863. doi: 10.1161/JAHA.112.003863. Epub 2012 Dec 19.
4
Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.体重指数与心脏性猝死的关系,以及心肌梗死后左心室功能障碍患者植入式心脏复律除颤器的获益。
Am J Cardiol. 2010 Mar 1;105(5):581-6. doi: 10.1016/j.amjcard.2009.10.041. Epub 2010 Jan 22.
5
Association of implantable defibrillator therapy risk with body mass index in systolic heart failure.植入式心脏除颤器治疗风险与射血分数降低的心力衰竭患者体重指数的相关性。
Heart Lung. 2013 Jul-Aug;42(4):257-61. doi: 10.1016/j.hrtlng.2012.12.008. Epub 2013 Jan 7.
6
Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.植入式心脏复律除颤器用于一级预防的心力衰竭患者合并症与预后的关系
J Am Heart Assoc. 2015 Aug 6;4(8):e002061. doi: 10.1161/JAHA.115.002061.
7
Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.非缺血性收缩性心力衰竭患者一级预防植入型心律转复除颤器的年龄和结局。
Circulation. 2017 Nov 7;136(19):1772-1780. doi: 10.1161/CIRCULATIONAHA.117.028829. Epub 2017 Sep 6.
8
Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS.在患有 2 型糖尿病和心血管疾病的患者中,肥胖与心血管结局的关系:来自 TECOS 的观察。
Am Heart J. 2020 Jan;219:47-57. doi: 10.1016/j.ahj.2019.09.016. Epub 2019 Oct 20.
9
Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.植入式心脏复律除颤器与2001年至2012年丹麦急性心肌梗死所致院外心脏骤停后的生存率:一项全国性研究
Eur Heart J Acute Cardiovasc Care. 2017 Mar;6(2):144-154. doi: 10.1177/2048872616687115. Epub 2017 Jan 6.
10
Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators.植入式心脏复律除颤器患者长期随访期间适当电击存在性别差异,但死亡率无性别差异。
Europace. 2016 Aug;18(8):1194-202. doi: 10.1093/europace/euv361. Epub 2015 Nov 29.

引用本文的文献

1
Association of waist circumference with long-term all-cause mortality and cardiac death in patients with a pacemaker: a retrospective study.起搏器植入患者腰围与长期全因死亡率及心源性死亡的关联:一项回顾性研究
BMC Cardiovasc Disord. 2025 Apr 12;25(1):283. doi: 10.1186/s12872-025-04671-2.
2
Global prevalence of obesity in the older adults: A meta-analysis.老年人肥胖的全球患病率:一项荟萃分析。
Public Health Pract (Oxf). 2025 Jan 18;9:100585. doi: 10.1016/j.puhip.2025.100585. eCollection 2025 Jun.
3
Trends in the 30-year span of noninfectious cardiovascular implantable electronic device complications in Olmsted County.

本文引用的文献

1
Trends in Obesity Among Adults in the United States, 2005 to 2014.2005年至2014年美国成年人肥胖趋势
JAMA. 2016 Jun 7;315(21):2284-91. doi: 10.1001/jama.2016.6458.
2
Obesity and Cardiovascular Disease.肥胖与心血管疾病。
Circ Res. 2016 May 27;118(11):1752-70. doi: 10.1161/CIRCRESAHA.115.306883.
3
The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial.心房颤动中的“肥胖悖论”:ARISTOTLE(阿哌沙班用于心房颤动减少卒中和其他血栓栓塞事件)试验的观察结果。
奥尔姆斯特德县非感染性心血管植入式电子设备并发症30年期间的趋势。
Heart Rhythm O2. 2024 Feb 14;5(3):158-167. doi: 10.1016/j.hroo.2024.02.001. eCollection 2024 Mar.
4
Paradoxical Prognostic Implications of Visceral Adiposity for Lethal Cardiac Events in Association with Impaired Cardiac Sympathetic Innervation in Chronic Heart Failure.内脏脂肪过多对慢性心力衰竭中与心脏交感神经去神经支配受损相关的致死性心脏事件的矛盾预后影响。
Ann Nucl Cardiol. 2020;6(1):15-26. doi: 10.17996/anc.20-00118. Epub 2020 Aug 31.
5
Sex Differences in the Relationship between Abdominal Obesity and Cardiovascular Death in Elderly Patients with Permanent Pacemakers Implantation: A Retrospective Cohort Study.老年永久性起搏器植入患者腹部肥胖与心血管死亡关系中的性别差异:一项回顾性队列研究
Evid Based Complement Alternat Med. 2023 Feb 17;2023:4383508. doi: 10.1155/2023/4383508. eCollection 2023.
6
Influence of diabetes on mortality and ICD therapies in ICD recipients: a systematic review and meta-analysis of 162,780 patients.糖尿病对 ICD 患者死亡率和 ICD 治疗的影响:一项纳入 162780 例患者的系统评价和荟萃分析。
Cardiovasc Diabetol. 2022 Jul 29;21(1):143. doi: 10.1186/s12933-022-01580-y.
7
Let It Beat: How Lifestyle and Psychosocial Factors Affect the Risk of Sudden Cardiac Death-A 10-Year Follow-Up Study.让它跳动:生活方式和心理社会因素如何影响心源性猝死的风险——一项为期 10 年的随访研究。
Int J Environ Res Public Health. 2022 Feb 24;19(5):2627. doi: 10.3390/ijerph19052627.
8
Absence of Obesity Paradox in All-Cause Mortality Among Chinese Patients With an Implantable Cardioverter Defibrillator: A Multicenter Cohort Study.中国植入式心律转复除颤器患者全因死亡率中不存在肥胖悖论:一项多中心队列研究。
Front Cardiovasc Med. 2021 Dec 3;8:730368. doi: 10.3389/fcvm.2021.730368. eCollection 2021.
9
Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator.超重和肥胖是植入式心脏复律除颤器治疗非缺血性心肌病患者死亡率的保护因素。
Clin Cardiol. 2020 Dec;43(12):1435-1442. doi: 10.1002/clc.23458. Epub 2020 Sep 16.
10
Relationship between diet quality and sarcopenia in elderly Koreans: 2008-2011 Korea National Health and Nutrition Examination Survey.2008 - 2011年韩国国民健康与营养检查调查:韩国老年人饮食质量与肌肉减少症之间的关系
Nutr Res Pract. 2020 Aug;14(4):352-364. doi: 10.4162/nrp.2020.14.4.352. Epub 2020 Jul 23.
Eur Heart J. 2016 Oct 7;37(38):2869-2878. doi: 10.1093/eurheartj/ehw124. Epub 2016 Apr 12.
4
Obesity paradox disappears in coronary artery bypass graft patients during 20-year follow-up.在 20 年的随访中,肥胖悖论在冠状动脉旁路移植患者中消失了。
Eur Heart J Acute Cardiovasc Care. 2017 Dec;6(8):771-777. doi: 10.1177/2048872616633844. Epub 2016 Feb 24.
5
Obesity and Prevalence of Cardiovascular Diseases and Prognosis-The Obesity Paradox Updated.肥胖与心血管疾病的患病率及预后——肥胖悖论的最新进展
Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):537-47. doi: 10.1016/j.pcad.2016.01.008. Epub 2016 Jan 28.
6
Update on Obesity and Obesity Paradox in Heart Failure.心力衰竭中肥胖及肥胖悖论的最新进展
Prog Cardiovasc Dis. 2016 Jan-Feb;58(4):393-400. doi: 10.1016/j.pcad.2015.12.003. Epub 2015 Dec 23.
7
Obesity and cardiovascular disease: friend or foe?肥胖与心血管病:敌是友非?
Eur Heart J. 2016 Dec 21;37(48):3560-3568. doi: 10.1093/eurheartj/ehv509. Epub 2015 Dec 18.
8
Smoking and reverse causation create an obesity paradox in cardiovascular disease.吸烟与反向因果关系在心血管疾病中造成了肥胖悖论。
Obesity (Silver Spring). 2015 Dec;23(12):2485-90. doi: 10.1002/oby.21239. Epub 2015 Sep 30.
9
Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosis.动脉粥样硬化血栓形成患者或有其风险者的心血管风险与体重指数及使用基于证据的预防药物的关系。
Eur Heart J. 2015 Oct 21;36(40):2716-28. doi: 10.1093/eurheartj/ehv347. Epub 2015 Aug 4.
10
Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure.慢性心力衰竭患者体重指数与全因死亡率、心血管死亡率及住院率关系的Meta分析
Am J Cardiol. 2015 May 15;115(10):1428-34. doi: 10.1016/j.amjcard.2015.02.024. Epub 2015 Feb 18.